These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Role of lipoxin in the modulation of immune response during infection. Machado FS; Aliberti J Int Immunopharmacol; 2008 Oct; 8(10):1316-9. PubMed ID: 18687293 [TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects. Detoraki A; Staiano RI; Granata F; Giannattasio G; Prevete N; de Paulis A; Ribatti D; Genovese A; Triggiani M; Marone G J Allergy Clin Immunol; 2009 May; 123(5):1142-9, 1149.e1-5. PubMed ID: 19275959 [TBL] [Abstract][Full Text] [Related]
31. Lipoxin A(4) metabolites/analogues from two commercial sources have no effects on TNF-alpha-mediated priming or activation through the neutrophil formyl peptide receptors. Forsman H; Dahlgren C Scand J Immunol; 2009 Oct; 70(4):396-402. PubMed ID: 19751275 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and anti-inflammatory effect of lipoxins in human airway epithelial cells. Bonnans C; Gras D; Chavis C; Mainprice B; Vachier I; Godard P; Chanez P Biomed Pharmacother; 2007 Jun; 61(5):261-7. PubMed ID: 17418999 [TBL] [Abstract][Full Text] [Related]
33. Neuropilin2 expressed in gastric cancer endothelial cells increases the proliferation and migration of endothelial cells in response to VEGF. Kim WH; Lee SH; Jung MH; Seo JH; Kim J; Kim MA; Lee YM Exp Cell Res; 2009 Aug; 315(13):2154-64. PubMed ID: 19409892 [TBL] [Abstract][Full Text] [Related]
34. Role of the low-affinity leukotriene B4 receptor BLT2 in VEGF-induced angiogenesis. Kim GY; Lee JW; Cho SH; Seo JM; Kim JH Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):915-20. PubMed ID: 19286633 [TBL] [Abstract][Full Text] [Related]
35. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction. Filep JG; Khreiss T; József L Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):257-62. PubMed ID: 15979865 [TBL] [Abstract][Full Text] [Related]
36. Lipoxin A4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment. Hao H; Liu M; Wu P; Cai L; Tang K; Yi P; Li Y; Chen Y; Ye D Cancer Lett; 2011 Oct; 309(1):85-94. PubMed ID: 21683517 [TBL] [Abstract][Full Text] [Related]
37. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1. Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137 [TBL] [Abstract][Full Text] [Related]
38. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Chiang N; Arita M; Serhan CN Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378 [TBL] [Abstract][Full Text] [Related]
39. Antiangiogenic properties of silver nanoparticles. Gurunathan S; Lee KJ; Kalishwaralal K; Sheikpranbabu S; Vaidyanathan R; Eom SH Biomaterials; 2009 Oct; 30(31):6341-50. PubMed ID: 19698986 [TBL] [Abstract][Full Text] [Related]